Arq. Bras. Oftalmol. 2019; 82 (3): 10.5935/0004-2749.20190043
Total: 1376
Renata Portella Nunes; Flávio Eduardo Hirai; Letícia Fernandes Barroso; Emmerson Badaró; Eduardo Novais; Eduardo Buchele Rodrigues; Mauricio Maia; Octaviano Magalhães Jr.; Michel Eid Farah
DOI: 10.5935/0004-2749.20190043
Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
Corresponding authorRenata Portella Nunes
Instituto de Olhos de Florianópolis
Rua Presidente Coutinho, 579/501
Florianópolis SC - 88015-231 - Brazil
E-mail: [email protected]
Funding: This study was supported by CNPq (558868/2009-6), FAPESP (2010/15451-0), and CAPES (BEX1059/12-2)
Disclosure of potential conflicts of interest: Dr. Rodrigues reports grants from Bayer and Allergan. The others authors declare having no conflicts of interest
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
